Showing results (241-250 of 367) with videos related to

Sort By:
Pageof 37
American Journal of Hematology|January 14, 2014
Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemiaMeagan A Jacoby, Michael G Martin, Geoffrey L Uy, et al.
Leukemia & Lymphoma|April 29, 2016
A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndromeMathew A Cherian, Raoul Tibes, Feng Gao, et al.
Blood|November 6, 2010
A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemiaTodd A Fehniger, Geoffrey L Uy, Kathryn Trinkaus, et al.
Bone Marrow Transplantation|July 29, 2014
A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myelomaT-F Wang, M A Fiala, A F Cashen, et al.
Transplantation and Cellular Therapy|May 22, 2022
Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related MortalityLawrence Wayne Liu, Alicia Yn, Feng Gao, et al.
JAMIA Open|April 25, 2024
Analysis of laboratory data transmission between two healthcare institutions using a widely used point-to-point health information exchange platform: a case reportHung S Luu, Walter S Campbell, Raja A Cholan, et al.
American Journal of Hematology|August 4, 2009
A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromesMike G Martin, Richard A Walgren, Elizabeth Procknow, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 19, 2011
Oral valganciclovir versus ganciclovir as delayed pre-emptive therapy for patients after allogeneic hematopoietic stem cell transplant: a pilot trial (04-0274) and review of the literatureJ S Chawla, A Ghobadi, J Mosley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host diseasePaul A Carpenter, James Lowder, Laura Johnston, et al.
Bone Marrow Transplantation|July 5, 2001
Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulinH Khoury, A Kashyap, D R Adkins, et al.
Pageof 37